FACTORS INFLUENCING OUTCOME OF PREDNISONE DOSE REDUCTION IN MYASTHENIA-GRAVIS

被引：33

作者：

MIANO, MA

BOSLEY, TM

HEIMANPATTERSON, TD

REED, J

SERGOTT, RC

SAVINO, PJ

SCHATZ, NJ

机构：

[1] WILLS EYE HOSP & RES INST, NEUROOPHTHALMOL SERV, 9TH & WALNUT ST, PHILADELPHIA, PA 19107 USA

[2] THOMAS JEFFERSON UNIV, DEPT INFECT DIS, PHILADELPHIA, PA 19107 USA

[3] LEHIGH VALLEY HOSP CTR, RES DEPT, ALLENTOWN, PA USA

来源：

NEUROLOGY | 1991年 / 41卷 / 06期

关键词：

D O I：

10.1212/WNL.41.6.919

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We reviewed retrospectively 114 prednisone dose reduction attempts in 63 myasthenic patients. Dose reduction was considered successful if a patient remained asymptomatic for more than 1 year on no prednisone or a stable low dose of prednisone. Successful dose reduction attempts were more common in patients taking azathioprine, but thymectomy did not influence taper outcome. Slower rate of dose reduction and higher ending dose of prednisone improved the chance of success.

引用

页码：919 / 921

页数：3

共 6 条

[1] PRESENT AND FUTURE TREATMENT OF MYASTHENIA-GRAVIS [J].